Podcasts about cardiovascular diseases

Welcome to this week's Midlife Minute! Today, I examine partial and full hysterectomies and what we know about their potential long-term effects, clarifying what the research tells us about bone, brain, and cardiovascular health, and what women should discuss with their healthcare providers before and after surgery. IN THIS EPISODE, YOU WILL LEARN: How a partial hysterectomy differs from a full hysterectomy, and the abrupt estrogen changes ovarian removal can produce  Why having a hysterectomy before ages 40-45 can have a greater impact than having surgery closer to natural menopausal age. How a hysterectomy can impact women's bone health What the research reveals about the connection between surgical menopause at a younger age, cognitive decline, and Alzheimer's pathology How a hysterectomy can affect women's cardiovascular health Why starting HRT early after an early-age hysterectomy could be important for your long-term health Why younger women who experience surgical menopause may require higher estradiol doses than the standard menopausal regimens The importance of advocating for yourself, understanding your personal risk, and talking with your clinician about estrogen and other hormone therapy before undergoing surgery Quotes: “Start those conversations early- before you ever have surgery.” “If you are having these surgeries done before 45, before 40, you need HRT!” “We have to manage our stress.” “We have to get enough sleep.” “We should be strength training.” “We should be physically active.” “We should be eating an anti-inflammatory diet.” Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Research: Increased Risk of Osteoporosis With Hysterectomy: A Longitudinal Follow-Up Study Using a National Sample Cohort. American Journal of Obstetrics and Gynecology. 2019. Choi HG, Jung YJ, Lee SW.  Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020. El Khoudary SR, Aggarwal B, Beckie TM, et al. Cardiovascular Disease After Hysterectomy in the Nurses' Health Study and Nurses' Health Study II. Obstetrics and Gynecology. 2025. Thao V, Borah B, Stewart EA, et al. Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause. The Journal of the American Medical Association. 2021. Kaunitz AM, Kapoor E, Faubion S. Hysterectomy, Oophorectomy, and Bone Health: A Systematic Review and Meta-Analysis. European Journal of Endocrinology. 2025. Shariful Islam M, Tuesley KM, Wilson LF, et al. Risk of Osteoporosis and Fracture After Hysterectomies Without Oophorectomies: A Systematic Review and Pooled Analysis. Osteoporosis International. 2022. Xu W, Wu W, Yang S, et al. Hysterectomies Are Associated With an Increased Risk of Osteoporosis and Bone Fracture: A Population-Based Cohort Study. PloS One. 2020. Yeh YT, Li PC, Wu KC, et al. Age at Surgical Menopause Influences Cognitive Decline and Alzheimer Pathology in Older Women. Neurology. 2014. Bove R, Secor E, Chibnik LB, et al. Reproductive Period and Risk of Dementia in a Diverse Cohort of Health Care Members. Neurology. 2019. Gilsanz P, Lee C, Corrada MM, et al.  Examining the Association of Hysterectomy With and Without Oophorectomy on Cardiovascular Disease and All-Cause, Cardiovascular or Cancer Mortality: A Systematic Review and Meta-Analysis. BJOG: An International Journal of Obstetrics and Gynecology. 2024. Chen Y, Li F, Liang L, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. The Journal of the American Medical Association. 2019. Honigberg MC, Zekavat SM, Aragam K, et al Optimizing Health After Early Menopause. Lancet. 2024. Mishra GD, Davies MC, Hillman S, et al. Hormone Replacement Therapy for Women Previously Treated for Endometrial Cancer. The Cochrane Database of Systematic Reviews. 2018. Edey KA, Rundle S, Hickey M.

John Maytham speaks to Dr Darshini Govindasamy, Director at PRICELESS SA, about South Africa's cardiovascular disease burden, the hidden danger of hypertension and the need for a more integrated approach to managing chronic health conditions. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Cardiovascular disease is the leading killer of women, yet most women are unaware of their risk. How do we help women navigate their risk at every age? Guest Gina Lundberg, MD, FACC, FAHA, describes aspects of pregnancy and menopause that can impact women's heart health.Resources: The Feminine Face of Heart Disease (AHA): https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.064460 PCNA CE course: Menopausal Hormone Replacement Therapy: https://pcna.net/course/menopausal-hormone-replacement-therapy/ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Preconception care is an important strategy for reducing lifelong CVD risk in women. Nicole Crossley, PhD, RN, RDNhttps://pcna.net/career-development/courses/?_topic=women-and-heart-disease, LD, FPCNA, shares strategies for implementing trusted, culturally-relevant care for all ages, especially high-priority populations that are most at risk.Related Resources:Primary prevention of CVD in women (ESC)2019 AHA/ACC Primary Prevention GuidelinePCNA courses on women and heart diseaseSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

To be added.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sleep, Growth Hormone, and Autophagy: How Rest, Diet, and Fasting Support Metabolic Health and Longevity: Nutritionist Leyla Muedin discusses how deep, early non-REM sleep boosts growth hormone for muscle, bone, fat burning, and metabolic health, and reviews a Cell study in which UC Berkeley researchers mapped hypothalamic circuits and feedback through the locus coeruleus showing a tight balance between sleep, growth hormone release, and wakefulness, with implications for metabolic disease and neurodegeneration. She connects poor sleep to higher blood sugar, insulin, and cortisol, which can suppress growth hormone, and advises avoiding sweet post-workout foods (e.g., smoothies, bananas, fruit yogurt) that stimulate insulin and blunt growth hormone, recommending protein and fat instead. She then explains autophagy and mitophagy as cellular cleanup processes linked to longevity, noting autophagy peaks after 12 hours of fasting, highlighting roles in mitochondrial quality control, immunity, and neurodegenerative disease, and mentions interventions such as fasting, exercise, ketogenic diets, and investigational inducers like rapamycin and urolithin A.

Today, I’ve got my good friend Joel Jamieson back for his final stop on the podcast! In this episode, we explore the science and practice of training for a longer, healthier life. As the title implies we spend a great deal of time covering cardiovascular disease, but we also discuss the differences between high- and low-intensity […] The post Joel Jamieson on Cardiovascular Disease, Longevity Training, and Avoiding the Law of Averages appeared first on Robertson Training Systems.

Welcome to the latest Midlife Minute. This episode unpacks ongoing research on Lp(a), explores how women's lipids change during the perimenopause-to-menopause transition, and clarifies what we can do about it. Stay tuned for more! IN THIS EPISODE, YOU WILL LEARN: How total cholesterol, LDL, and ApoB tend to rise most steeply around the final menstrual period, rather than increasing gradually with chronological aging Why women should have their Lp(a) checked both before and after menopause How oral and transdermal estradiol can affect LDL, HDL, triglycerides, and Lp(a) differently Why I recommend including ApoB when checking your lipids during the perimenopause window How your lifestyle can reduce your cardiovascular risk, even when your Lp(a) is elevated Why omega-3 fatty acids and commonly used lipid medications do not lower Lp(a) Why supplements are not replacements for statins in genuinely high-risk patients  I review the various PCSK9 inhibitors currently available, how they are administered, and their effects  How a CAC, a CT angiogram, and an AI-assisted CT angiogram can help women and their providers determine how aggressive their approach should be when Lp(a) is elevated Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line References: 1. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.Circulation. 2020. El Khoudary SR, Aggarwal B, Beckie TM, et al.Guideline 2. Menopause: A Cardiometabolic Transition. The Lancet. Diabetes & Endocrinology. 2022. Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T.Review 3. Dyslipidemia Across the Menopause Transition: Mechanisms, Trajectories, and Opportunities for Cardiovascular Prevention. Maturitas. 2026. Castaneda R, Tatit CP, Hurtado Andrade MD, Faubion SS, Shufelt CL.RecentReview 4. Lipoprotein(a) and Women's Cardiovascular Health: A Review. JACC. Advances. 2026. Michos ED, Saucier S, Mehran R, Koschinsky ML. 5. Lipid Metabolism in Women: A Review. Atherosclerosis. 2025. van Oortmerssen JAE, Mulder JWCM, Kavousi M, Roeters van Lennep JE.Review 6. Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?. Journal of the American College of Cardiology. 2009. Matthews KA, Crawford SL, Chae CU, et al.Observational 7. Trajectories of Lipids Around the Menopause Transition in Chinese Women: Results of the Kailuan Cohort Study. Fertility and Sterility. 2023. Dai Q, Wu S, Cao Z, et al. 8. Lipid Management in Patients With Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 2020. Newman CB, Blaha MJ, Boord JB, et al.Guideline 9. The Effects of Menopause Hormone Therapy on Lipid Profile in Postmenopausal Women: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 2022. Nie G, Yang X, Wang Y, et al.SR 10. Perspectives on Dyslipidemia and Coronary Heart Disease in Women. Journal of the American College of Cardiology. 2005. Bittner V.Review 11. Dyslipidemia in Midlife Women: Approach and Considerations During the Menopausal Transition. Maturitas. 2022. Torosyan N, Visrodia P, Torbati T, Minissian MB, Shufelt CL.Review 12. Effects of gender, age and menopausal status on serum apolipoprotein concentrations.13.Lipoprotein(a).The Journal of the American Medical Association. 2025. Mora S, Kronenberg     14. Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications. Diabetes, Obesity & Metabolism. 2025. Razavi AC, Bhatia HS, Blumenthal RS, Shapiro MD, Mehta A.RecentReview 15. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. Journal of the American College of Cardiology. 2021. Cicero AFG, Fogacci F, Zambon A.Review 16. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Drugs. 2023. Blais JE, Huang X, Zhao JV.SR 17. Non-Genetic Influences on Lipoprotein(a) Concentrations. Atherosclerosis. 2022. Enkhmaa B, Berglund L.Review 18. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. Journal of the American College of Cardiology. 2018. Tsimikas S, Fazio S, Ferdinand KC, et al.Review 19. Consumption of a defined, plant‐based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks. Clinical Cardiology. 2018. Najjar RS, Moore CE, Montgomery BD. 20. Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies. Clinical Therapeutics. 2019. Santos HO, Kones R, Rumana U, et al.Review 21. Effect of Lipid-Lowering Therapies on Lipoprotein(a) Levels: A Comprehensive Meta-Analysis of Randomized Controlled Trials. Atherosclerosis. 2025. Xie S, Galimberti F, Olmastroni E, et al.Recent 22. Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia. Journal of Atherosclerosis and Thrombosis. 2023. Ying Q, Croyal M, Chan DC, et al.RCT 23.Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024. Nordestgaard BG, Langsted A.Review 24. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology. 2022. Reyes-Soffer G, Ginsberg HN, Berglund L, et al.Guideline 25.Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3.Journal of the American College of Cardiology. 2023. Malick WA, Goonewardena SN, Koenig W, Rosenson RS.Review 26.2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American Collegeof Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026. Writing Committee Members, Blumenthal RS, Morris PB, et al.Guideline 27. Noninvasive Coronary Atherosclerotic Plaque Imaging. JACC. Cardiovascular Imaging. 2023. Kwiecinski J, Tzolos E, Williams MC, et al.Review 28. Computed Tomography Angiography Versus Agatston Score for Diagnosis of Coronary Artery Disease in Patients With Stable Chest Pain: Individual Patient Data Meta-Analysis of the International COME-CCT Consortium. European Radiology. 2022. Wieske V, Walther M, Dubourg B, et al.SR 29. Association of Coronary Artery Calcium Score With Qualitatively and Quantitatively Assessed Adverse Plaque on Coronary CT Angiography in the SCOT-HEART Trial. European Heart Journal. Cardiovascular Imaging. 2022. Osborne-Grinter M, Kwiecinski J, Doris M, et al.Clinical Trial 30. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. JACC. Cardiovascular Imaging. 2024. Nurmohamed NS, Bom MJ, Jukema RA, et al.Observational 31. The Lancet Commission on Rethinking Coronary Artery Disease: Moving From Ischemia to Atheroma. Lancet. 2025. Zaman S, Wasfy JH, Kapil V, et al.Review 32. Efficacy and safety of novel lipoprotein(a)‐targeted therapies: A systematic review and meta‐analysis of randomized controlled trials. Diabetes, Obesity & Metabolism. 2026. Santana AUL, Yusufzai MO, Freitas APS, et al. Recent Opinion

Join Alison Stephens, PA-C, as she defines PSVT (paroxysmal supraventricular tachycardia), explores its impact on patients' quality of life, and discusses various treatment options, including a new FDA-approved nasal spray.CE units are available for this episode only through June 15, 2027. To access CE, visit pcna.net/course/spotlight-on-psvt/.Related PCNA Resources:​​- Patient Journey: PSVT Strikes Anytime, Anyplace - https://pcna.net/resource/patient-journey-psvt-strikes-anytime-anyplace-video/​- PSVT: Barriers and Solutions to the Disease Burden for Patients - https://pcna.net/resource/psvt-barriers-and-solutions-to-the-disease-burden-for-patients/- Living with PSVT: A Patient-Centered Care Plan ​- Living with PSVT: Episodic Rapid Heart Rates - https://pcna.net/podcast/living-with-psvt-a-patient-centered-care-plan/Related Episode Resources:- Self-Administered Etripamil and Emergency Department Visits in Supraventricular Tachycardia - https://jamanetwork.com/journals/jamacardiology/fullarticle/2832045- Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial - https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00776-6/fulltext- Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia - https://pubmed.ncbi.nlm.nih.gov/27754882/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This podcast episode explores transitions of care for patients with PSVT (paroxysmal supraventricular tachycardia), featuring insights from Alison Stephens, PA-C and Todd Wagner, RN. They discuss diagnosis, treatment pathways and the importance of patient education, follow-up care, and addressing social determinants of health to prevent recurrence and improve outcomes. CE units are available for this episode only through June 15, 2027. To access CE, visit pcna.net/course/spotlight-on-psvt/.Related PCNA Resources​​- Patient Journey: PSVT Strikes Anytime, Anyplace - https://pcna.net/resource/patient-journey-psvt-strikes-anytime-anyplace-video/​- PSVT: Barriers and Solutions to the Disease Burden for Patients - https://pcna.net/resource/psvt-barriers-and-solutions-to-the-disease-burden-for-patients/​- Living with PSVT: A Patient-Centered Care Plan - https://pcna.net/podcast/living-with-psvt-a-patient-centered-care-plan/​- Living with PSVT: Episodic Rapid Heart Rates - https://pcna.net/podcast/living-with-psvt-episodic-rapid-heart-rates-psvt-afib-and-more/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Paying attention to injuries may speed healing—could pain meds blunt the healing response? Fact check: “Everyone over 70 should take a statin”? Billy Joel's “brain surgery”; How to live past 100—get condemned to “death row”; Are vegans hotter than meat eaters? Promising lp(a) drug fails crucial test; Pain under the left rib cage—what are the possibilities? 

Welcome to the latest Midlife Minute. Today, I'm answering listeners' questions about cardiovascular risk, focusing on Lp(a), LDL, statins, and the changes women experience after menopause. Stay tuned for more! IN THIS EPISODE, YOU WILL LEARN: Why women should have their Lp(a) checked both before and after menopause How Lp(a) works as a risk enhancer, and how cardiovascular risk becomes more significant when elevated Lp(a) occurs alongside high LDL Why family history is particularly helpful for women with a 10-year calculated cardiovascular risk that looks reassuringly low I review the current guidelines for primary prevention Why, even though research has shown reductions in major cardiac events with GLP-1s, GLP-1s do not replace statins for lowering LDL  What a CAC score can reveal about coronary artery calcification, and what it cannot detect How AI-assisted CT angiography (such as Clearly) can map, quantify, and characterize plaque throughout the coronary branches Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line References: 1.  ​Lipoprotein(a) and Women's Cardiovascular Health: A Review. JACC. Advances. 2026. Michos ED, Saucier S, Mehran R, Koschinsky ML.Recent 2.  ​Sex Differences of Lipoprotein(a) Levels and Associated Risk of Morbidity and Mortality by Age: The Copenhagen General Population Study. Atherosclerosis. 2022. Simony SB, Mortensen MB, Langsted A, et al. 3. Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2022. Stone NJ, Smith SC, Orringer CE, et al.Review 4. Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a). JAMA Cardiology. 2026. Nordestgaard AT, Chasman DI, Moorthy V, et al.RecentObservational 5.  ​Lipoprotein(a).The Journal of the American Medical Association. 2025. Mora S, Kronenberg  6. Clinical Practice Guideline on Lipid Management for Cardiovascular Disease Risk Reduction. Department of Veterans Affairs (2026). 2026. Paul Heidenreich, Lance Spacek, Neil Gregor, et al. Guideline 7. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk. Journal of the American College of Cardiology. 2020. Mehta A, Virani SS, Ayers CR, et al.Observational 8. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2010. Greenland P, Alpert JS, Beller GA, et al.Guideline 9. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women. The Journal of the American Medical Association. 2016. Kavousi M, Desai CS, Ayers C, et al.SR 10. ​Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as “Low Risk” Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis (MESA). Archives of Internal Medicine. 2007. Lakoski SG, Greenland P, Wong ND, et al.Observational 11. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2019. Arnett DK, Blumenthal RS, Albert MA, et al.Guideline 12. HOPE for Rational Statin Allocation for Primary Prevention: A Coronary Artery Calcium Picture Is Worth 1000 Words. Mayo Clinic Proceedings. 2020. Orringer CE, Maki KC.Review 13. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020. Cho L, Davis M, Elgendy I, et al.Review 14. Health Maintenance in Postmenopausal Women. American Family Physician. 2025. Plesa M, Wong A, Katsaggelos E.Guideline 15.  ​Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT. Diabetes Care. 2024. Lingvay I, Deanfield J, Kahn SE, et al.RCT 16.  ​Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England Journal of Medicine. 2023. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.RCT 17. Long-Term Weight Loss Effects of Semaglutide in Obesity Without Diabetes in the SELECT Trial. Nature Medicine. 2024. Ryan DH, Lingvay I, Deanfield J, et al.RCT 18. Interventions for the Prevention and Management of Cardiometabolic Multiple Long-Term Conditions. Lancet. 2026. Valabhji J, Hope D, Sayed NE, et al.RecentReview 19. Glucagon‐Like Peptide‐1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta‐Analysis of Randomized‐Controlled Trials. Clinical Cardiology. 2024. Hosseinpour A, Sood A, Kamalpour J, et al.SR 20. ​FDA Orange Book. FDA Orange Book. 2026. 21. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026. Diabetes Care. 2026. American Diabetes Association Professional Practice Committee for Diabetes*.RecentGuideline 22. Premature Coronary Artery Disease in Women: Sex-Specific Risk Factors, Pathogenetic Mechanisms and Clinical Implications. Annals of Medicine. 2026. Li F, Hong D, Yang M, et al.RecentReview 23. Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association. Circulation. 2023. Mehta LS, Velarde GP, Lewey J, et al.Guideline 24. Preventing CVD in Women: Common Questions and Answers. American Family Physician. 2023. Westfall E, Viere AB, Genewick JE.Review 25. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020. El Khoudary SR, Aggarwal B, Beckie TM, et al.Guideline

The ACOG PB 222 states, “In women with preeclampsia with severe features at less than 34 0/7 weeks of gestation, with stable maternal and fetal condition, expectant management may be considered”. The expectant management of preeclampsia with severe features before 34 0/7 weeks of gestation is based on strict selection criteria of those appropriate candidates and is best accomplished in a setting with resources appropriate for maternal and neonatal care. BOX 4 in that ACOG guidance lists “Conditions Precluding Expectant management”, with one of the conditions being “Uncontrolled severe-range blood pressures (persistent systolic blood pressure 160 mm Hg or more or diastolic blood pressure 110 mm Hg or more not responsive to antihypertensive medication” (i.,e. persistent and refractory to appropriate medication). But what defines “uncontrolled hypertension”? When is preterm delivery indicated based on that feature? In this episode, we will answer this real-world clinical question. So, for a patient who is otherwise stable, asymptomatic, without HELLP syndrome, whose fetus is stable but is under 34 weeks, when can “uncontrolled hypertension” be diagnosed to prompt delivery? Listen in for details as we highlight the 2022 SMFM Special Report on that matter. 1. ACOG PB 2222. SMFM Special report: Preeclampsia: a report and recommendations of the workshop of the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation, Nov 20223. De Backer J, Haugaa KH, Hasselberg NE, et al. 2025 ESC Guidelines for the Management of Cardiovascular Disease and Pregnancy. European Heart Journal. 20254. SOGC Clinical Practice Guideline: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary; No. 307, May 20145. ISSHP (2018): The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Preg Hypertension. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/http://www.isshp.org/wp-content/uploads/2018/06/1-s2.0-S2210778918301260-main.pdf

Plus: Amgen has its worst day in more than two decades. And quantum-computing companies rally after U.S. government picks up minority stakes. Imani Moise hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

High cholesterol can start damaging your arteries long before you feel anything — and your total cholesterol number does not tell the whole story. So when should you start checking it, what do LDL and other cholesterol particles really mean, and when are lifestyle changes no longer enough?In this episode of Baptist Health Talk, host Dr. Anthony Gonzalez speaks with Dr. Sanjeev Gulati about how cholesterol contributes to heart attacks and heart failure, why screening should begin earlier than many people think, and the treatment options available today. Why high cholesterol is directly linked to heart attack risk  Common cholesterol myths, including the idea that diet is the only cause  How LDL and lipoprotein(a) contribute to plaque buildup and inflammation  How uncontrolled cholesterol can ultimately contribute to heart failure  Why cholesterol screening may need to begin in your 20s  How family history and familial hypercholesterolemia change cardiovascular risk  Lifestyle steps that can help lower cholesterol  When cholesterol-lowering medication may be needed  Why cholesterol control remains critical even after a heart attack  How advanced lipid testing can provide a clearer picture of individual riskHost:Anthony Gonzalez, M.D.Chief of Surgery, Baptist Health Baptist HospitalMedical Director of Bariatric Surgery, Baptist HealthGuest:Sanjeev Kumar Gulati, M.D., Executive Deputy DirectorSystem Chief of Cardiovascular MedicineBaptist Health Heart & Vascular CareIf you found this episode helpful, we also recommend:What Your Blood Pressure and Cholesterol Numbers Really MeanCalcium Scores Explained: What Your Heart Rick Really Looks LikeHeart Disease in Young Adults: Why It's Rising (And What to Watch For)

Join guest Dana Miller, Advanced HF Nurse Practitioner, to discuss the science and evidence to turn the tide on ATTR. Dana provides an overview of recent clinical trials and how an ATTR-CM diagnosis impacts rate of hospitalization, mortality and quality of life. Dana shares resources and recommendations to continue to learn more about the ever-evolving ATTR-CM treatment and management strategies.Related PCNA Resources:The Role of Artificial Intelligence in Cardiovascular Care: ATTR Case Study (CE Course) Heart Failure and ATTR-CM: A Guide for Health Care Professionals Hereditary Amyloidosis: What you need to know fact sheet Related Episode Resources:CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisTransthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical GuidanceChanging Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort StudyOutcomes in patients with cardiac amyloidosis undergoing catheter ablation for atrial arrhythmiasAmyloidosis Research ConsortiumHeart Failure Society of America (HFSA)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join guest Emily Brown, a Cardiovascular Genetic Counselor who has worked with ATTR-CM patients for over a decade. Emily dives into the role of genetic testing in diagnostics and personalized therapies. Emily shares practical strategies and examples of team based care with a multi-disciplinary care team to tackle turning the tide on ATTR-CM. Emily shares suggestions for resources and support for genetic testing for patients.Related PCNA Resources:The Role of Artificial Intelligence in Cardiovascular Care: ATTR Case Study (CE Course) Heart Failure and ATTR-CM: A Guide for Health Care Professionals Hereditary Amyloidosis: What you need to know fact sheet Related Episode Resources:ForgingBridges - Resources to help support you and your patients See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join guest Morgan Lewis, an Amyloid Nurse Clinician, to learn about how ATTR-CM impacts patient's quality of lives. Morgan describes the variants of ATTR-CM as well ad dives into the ongoing unmet needs of patients iwth ATTR-CM. Morgan shares practical examples to overcome challenges to patient care and optimal health outcomes using team-based care strategies.Related PCNA Resources:The Role of Artificial Intelligence in Cardiovascular Care: ATTR Case Study (CE Course)Heart Failure and ATTR-CM: A Guide for Health Care ProfessionalsHereditary Amyloidosis: What you need to know fact sheetSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome to SEASON SEVEN, Superwomen!  I'm so excited to be back in your listening ears, and I'm truly pumped for what this season is going to look like. This podcast started in 2019, pulled us all through the last seven years, and we are now entering the 147th episode, in the seventh season. Holy cow!  Today on the podcast, I'm asking a very important question... "What if your periods could give us clues about the health you'll need to protect ten, twenty or thirty years from now — even if there was never anything "wrong" with them?" We'll explore why hormone and reproductive health belong in the preventative-health conversation. We look at what menstrual cycles, pregnancy history, PCOS, perimenopause and menopause can tell us about cardiovascular health, metabolic health, body composition, bone and healthspan. But this isn't an episode about looking for hormone problems. A normal menstrual history is information. An uncomplicated pregnancy is information. The timing and pattern of perimenopause are information too. We'll look at how reproductive history can help us understand health trajectory earlier — and why something doesn't have to be wrong before it becomes useful information. Hormones are data, not destiny. The goal is to use that data to build better preventative-health plans long before we're treating the outcomes we're trying to prevent. RESEARCH USED IN THIS EPISODE Global Healthspan-Lifespan Gaps Among 183 WHO Member States — Garmany & Terzic, JAMA Network Open, 2024. This is the study behind the discussion that women have a wider healthspan-lifespan gap than men. JAMA Network Open full article | PubMed Menstrual Cycle Regularity and Length Across the Reproductive Lifespan and Risk of Cardiovascular Disease — Wang et al., JAMA Network Open, 2022; 80,630 women followed for 24 years. JAMA Network Open full article | PubMed Menstrual Cycle Regularity and Length Across the Reproductive Lifespan and Risk of Premature Mortality — Wang et al., BMJ, 2020; 79,505 women followed prospectively. PubMed Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease — Mishra et al., JAMA Cardiology, 2020; pooled data from 307,855 women. JAMA Cardiology full article | PubMed Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women — American Heart Association Scientific Statement, Circulation, 2021. PubMed Gestational Diabetes and the Risk of Cardiovascular Disease in Women: A Systematic Review and Meta-analysis — Kramer et al., Diabetologia, 2019; more than 5.3 million women. PubMed Hypertensive Disorders of Pregnancy and Risk of Cardiovascular Disease-Related Morbidity and Mortality — systematic review/meta-analysis involving more than 13 million women. PubMed Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention — American Heart Association Scientific Statement, Circulation, 2020. This is one of the most important papers supporting the episode's preventative-health framing of perimenopause. PubMed Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition? — SWAN; Matthews et al., JACC. The study separating age-related changes from menopause-associated changes in LDL, total cholesterol and ApoB. PubMed Changes in Body Composition and Weight During the Menopause Transition — SWAN; Greendale et al., 2019. Fat gain accelerated and lean mass declined around the menopause transition without a corresponding acceleration in overall weight gain. PubMed Abdominal Visceral Adipose Tissue Over the Menopause Transition and Carotid Atherosclerosis — SWAN Heart Study, 2021. PubMed Bone Mineral Density Loss in Relation to the Final Menstrual Period — SWAN; Greendale et al., 2012. The research behind our discussion of the accelerated bone-loss window around menopause. PubMed

Nutrition Nugget! Bite-sized bonus episodes offer tips, tricks and approachable science. This week, Jenn is talking about Kombucha. Is this fizzy, tangy drink really the gut health hero everyone on social media claims it to be, or is it just another trendy beverage riding the wellness wave straight into your grocery store fridge? Jenn digs into what kombucha is, how it is made, and what the research says about its impact on digestion, immunity, skin, blood sugar, and even your liver. There is a lot to like here, and yet there are also a few catches that most labels will not tell you, from hidden sugar to a serving size most people are drinking way past. So is kombucha worth the hype, or the price tag? Jenn breaks down both sides before landing on her verdict. Like what you're hearing? Be sure to check out the full-length episodes of new releases every Wednesday. Have an idea for a nutrition nugget? Submit it here: https://asaladwithasideoffries.com/index.php/contact/ RESOURCES:Become a Happy Healthy Hub MemberJenn's Free Menu PlanA Salad With a Side of FriesA Salad With A Side Of Fries MerchA Salad With a Side of Fries InstagramA Review on Kombucha Tea—Microbiology, Composition, Fermentation, Beneficial Effects, Toxicity, and Tea Fungus - Jayabalan - 2014National Library of Medicine Article - Microbial and Chemical Profiles of Commercial Kombucha ProductsThe Effect of ProbioticsHow Probiotics Can Help You Lose Weight and Belly FatNational Library of Medicine Article - Chemical Constitution and Antimicrobial Activity of Kombucha Fermented BeverageNational Library of Medicine Article: Hepatoprotective Properties of Kombucha Tea Against TBHPNational Library of Medicine Article - Green Tea and the Risk of Prostate CancerNational Library of Medicine Article - Green Tea Consumption and Risk of Breast CancerNational Library of Medicine Article - An Inverse Association Between Tea Consumption and Colorectal Cancer RiskTaylor & Francis - A Review on Health Benefits of Kombucha Nutritional Compounds and MetabolitesScienceDirect: Downregulation of Signaling Molecules Involved in Angiogenesis of Prostate Cancer Cell Line (PC-3) by Kombucha ScienceDirect: Effect of Green Tea Extract on Obese Women: A Randomized, Double-blind, Placebo-controlled Clinical TrialNational Library of Medicine Article - Hypoglycemic and Antilipidemic Properties of Kombucha Tea in Alloxan-Induced Diabetic RatsNational Library of Medicine Article - Kombucha Tea as an Anti-hyperglycemic Agent in Humans with Diabetes – a Randomized Controlled Pilot InvestigationNational Library of Medicine Article - Glycemic Index and Insulin Index after a Standard Carbohydrate Meal Consumed with Live Kombucha: A Randomized, Placebo-controlled, Crossover Trial National Library of Medicine Article - Green Tea Catechins Prevent Low-density Lipoprotein Oxidation via their Accumulation in Low-density Lipoprotein Particles in HumansNational Library of Medicine Article - Protective Effect of Kombucha on Rats Fed a Hypercholesterolemic Diet is Mediated by its Antioxidant ActivityNational Library of Medicine Article - Does Tea Affect Cardiovascular Disease? A Meta-AnalysisCDC - Unexplained Severe Illness Possibly Associated with Consumption of Kombucha Tea -- Iowa, 1995Mayo Clinic - Kombucha Tea: Does it Have Health Benefits?Jenn Trepeck, Nutrition Nugget, Salad With A Side Of Fries, Health Tips, Wellness Tips, Kombucha and Gut Health, Kombucha Benefits, Kombucha, Fermented Tea, Scoby, Symbiotic Colony Of Bacteria And Yeast, Gut Health, Probiotics, Microbiome Diversity, Digestive Health, Immune System Support, Skin Health, Antioxidants, Acetic Acid, Antibacterial Properties, Green Tea, Black Tea, Liver Support, Liver Toxicity, Cancer Prevention, Polyphenols, Cardiovascular Disease, Metabolic Health, Weight Management, Blood Sugar Balance, Fasting Blood Sugar, Glycemic Response, Cholesterol Levels, Belly Fat Reduction, Calories Burned, Soda Alternative, Sugar Content, Food Additives, Serving Size, Fermentation Process, Alcohol Content, Caffeine Content, Wellness Trends, Nutrition Coaching, Healthy Beverages, Functional Foods, Weight Loss, Health Benefits Of Drinking Kombucha Daily, Does Kombucha Help With Gut Health And Weight Loss

Food as Medicine: Why Medical Nutrition Therapy and Medically Tailored Meals Belong in Modern Healthcare: Registered dietitian nutritionist Leyla Muedin argues that food should be treated with the same rigor as medication through medical nutrition therapy (MNT) and “diet prescriptions,” integrating nutrition into treatment plans rather than leaving it as optional advice. She cites evidence that medically tailored meals (MTMs) can improve outcomes and reduce costs, including a Health Affairs simulation estimating $23.7B in first-year net savings nationwide and a Nature Medicine analysis of a Massachusetts Medicaid demonstration (2020–2023) showing MTM recipients had 31% fewer hospitalizations, 20% fewer emergency visits, and $3,433 lower total healthcare costs, offsetting 98% of program costs. She discusses food insecurity, expanding Medicaid coverage via Section 1115 waivers, EHR integration, and how MTMs support adherence for conditions such as diabetes, cardiovascular disease, chronic kidney disease, depression, and IBS (including low FODMAP).

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Nick van Osta from Maastricht University. They discuss a review paper on computational modelling in cardiovascular disease. They cover the use of AI for: ECG diagnosis automatic ejection fraction segmentation from echocardiography prediction of success in cardiac resynchronisation therapy If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper: "Individual hearts: computational models for improved management of cardiovascular disease" - https://heart.bmj.com/content/112/11/589  

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Dinesh Kalra and Khadijah Breathett discuss the estimated future projections of risk factors for CVD, individual CVD conditions (i.e. heart failure), and total CVD from 2020 to 2050 according to SDOH of the U.S. using the National Health and Nutrition Examination Survey, Medical Expenditure Panel Survey, and U.S. Census.

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

Cardiovascular disease is a major threat to maternal health during pregnancy and the peripartum period, particularly for women with preexisting heart conditions. A UC San Diego cardiologist describes the development of a multidisciplinary cardio-obstetrics initiative designed to coordinate care for patients with congenital heart disease, heart failure, arrhythmias and coronary artery disease. The program brings cardiology and maternal-fetal medicine together with other specialties to establish consistent protocols, improve maternal and fetal outcomes, advance research and train future clinicians. As more people born with congenital heart disease survive into adulthood and consider pregnancy, the need for this specialized care continues to grow. Longitudinal surveillance is also helping researchers study outcomes and identify opportunities for better monitoring. Coordinated cardio-obstetrics care can help manage complex cardiovascular risks throughout pregnancy and delivery. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41641]

What is a nurse scientist, and what is the difference between one that is PhD-prepared versus DNP-prepared? Guest Dawn Aycock, PhD, RN, ANP-BC, FAHA, FPCNA, FAAN, shares about the importance of nurse engagement in research, and how to get involved, no matter your role or location.Related PCNA Resources:Presenting Your Work: Call for Abstracts: https://pcna.net/events-news/cardiovascular-nursing-symposium/call-for-abstracts/Empowering CV Nurses to Engage in Clinical Research (article): https://pcna.net/news/empowering-cardiovascular-nurses-to-engage-in-clinical-research/Clinical Research: Engaging with the Community (podcast): https://pcna.net/podcast/clinical-research-engaging-with-the-community/About Research and Evidence-Based Practice (article): https://pcna.net/health-topics/research-and-evidence-based-practice/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

For new graduates of nurse practitioner programs, cardiovascular-focused knowledge and skills can be improved with additional professional development opportunities. Guest Michelle Alland, APRN, AGACNP-BC, MSN, FNP-C, AACC, describes postgraduate fellowships, local and national training options, onboarding, and the importance of mentorship from more tenured NPs.RELATED PCNA RESOURCES:Professional DevelopmentAwardsAbstractsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Commentary by Dr. Barry Franklin.

Commentary by Dr. Hyeon Chang Kim.

Commentary by Dr. Fu-Zong WU.

Commentary by Dr. Kevin Tang.

Commentary by Dr. Xin Zhou.

Most mayos, salad dressings and chips “made with 100% avocado oil” fail test; Borderline cholesterol—will a coronary calcium scan help decide whether a statin is warranted? Aged Garlic Extract for blood pressure; Immune benefits of BWH Beta Glucan. 

This week, we kick off a 4-part series on the 7th-largest cause of dearth in America.  In this episode, you'll find out:—How Diabetes is one of the major factors that contributes to other causes of death such as Cardiovascular Disease, Kidney Disease, Cancer, and Alzheimer's.—The shocking number of Diabetes patients that are undiagnosed.  And the large percentage of America's population that are classified as having Pre-Diabetes, which affects over half of Senior Citizens.—The difference between Type I 1 Type 2 Diabetes.  And the unforgettable Uber Driver illustration Dr. Prather uses to explain how Diabetes works. —How Type 1 Diabetes used to be called "Juvenile Diabetes", but that is no longer the case as it is being found in adults as well. —The role viruses play in causing Diabetes. —How breastfeeding reduces the chances of a child developing Diabetes in the future. —Why the increased number of chemicals in our food has increased Diabetes and insulin resistance, which Dr. Prather says they are finding in "everybody" now.—The way GLP-1 drugs actually damage the body's own ability to produce GLP-1 naturally. —The racial and genetic factors involved in who is more likely to develop Type 1 or Type 2 Diabetes.  And the amazing story of how Dr. Prather helped a Native American  patient to reverse his his extremely high Triglycerides by changing the kind of meat he was eating. —Why Alzheimer's Disease has been called Type 3 Diabetes. http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

Managing High Homocysteine with MTHFR Variants and the Role of Vitamin C in Brain Aging: Registered dietitian nutritionist Leyla Muedin discusses MTHFR genetic variants (C677T and A1298C), their links to impaired methylation, homocysteine, SAMe, mood issues, migraines, vitamin deficiencies, and pregnancy complications, noting many people are asymptomatic and some feel worse on methylated B vitamins and do better on standard formulations. Responding to a listener with C677T, high homocysteine, and borderline methylmalonic acid, she reviews optimal homocysteine targets and outlines other causes of elevated homocysteine such as hypothyroidism/subclinical hypothyroidism, kidney failure, obesity, hypertension, diabetes, smoking, inactivity, and medications (atorvastatin, methotrexate, fenofibrate). She suggests checking these factors, considering absorption issues (intrinsic factor) for B12, and trialing SAMe and more trimethylglycine, with possible pharmacologic folate if needed. She then summarizes an observational Japanese study (n=2,044 adults >64) linking lower plasma vitamin C to reduced gray matter and weaker default mode network connectivity, and notes diet and blood sugar can affect vitamin C status.

Hosts: Ed Jones (Owner – Nutrition World) & Clint Powell A variety of topics to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: Beyond Cholesterol: The Heart Health Markers That Matter [0:00:00] – Intro: Lettuce Contamination, Social Media & Local Business Impact Discussion of “fear of lettuce,” limited to 15 states (not Tennessee) How social media amplifies food scares Local “Build a Salad” restaurant going out of business and timing around lettuce scare [0:04:39] – Back-to-School Immune Support: Oral Probiotics & Iodine Nasal Spray Back-to-school season and rise in colds/sicknesses Oral probiotics for kids: oral microbiome, throat/sinus benefits Iodine nasal spray for parents and teachers: safety, use during school/gym, personal routines of Ed and Clint [0:08:04] – Supplement Industry & Big Pharma Buyouts Thorne bought by Procter & Gamble for $3.8B History of pharma mocking “granola/hippie” supplement culture, now buying brands Many acquired supplement brands failing under pharma ownership Difference between pharma customers and nutraceutical users (education, mindset) Nutrition World's preference for privately owned brands [0:14:00] – Life Lessons from Flying & Racing: Doing the Hard but Right Thing Ed's story: practicing engine-out landings, re-learning best glide speed Insight: sometimes you must “point the nose down” (do the counterintuitive hard thing) to survive Clint's race-car analogy: “you go where you look” – look down the track, not at the wall [0:18:01] – Food Label Claims: Olive Oil vs. Avocado Oil Products UC Davis testing of products “made with olive oil” – most passed authenticity tests Avocado-oil-labeled products often failing purity tests Takeaway: be more skeptical of “made with avocado oil” claims [0:18:31] – Prostate Cancer & “Treating the Terrain,” Not Just the Tumor Dr. Gio (prostate-focused naturopath): focus on the ground cancer grows in Historical context from Stephen Paget's work on tumor “soil and seed” Lifestyle “soil-building” recommendations: Resistance training, walking 150 minutes/week Waist circumference < half your height Sleep, stress reduction, nutraceuticals, nutrient-dense diet [0:21:58] – Multivitamins, Carotid Stenosis & Functional Benefits COSMOS study: Centrum multivitamin and patients with carotid narrowing Reported improvements in physical function (walking, climbing stairs) and symptoms (shortness of breath, fatigue) Ed's extrapolation: better-designed multis (True Grace, Life Extension, etc.) likely offer even more benefit [0:22:30] – Post-Infectious Cough: Honey + Instant Coffee vs. Prednisone Double-blind RCT comparing: Honey + instant coffee paste Prednisone Guaifenesin Honey + instant coffee dramatically outperformed prednisone in reducing persistent cough frequency Discussion of guaifenesin's role, safety, and its regulatory history in health food vs. pharmacy channels [0:30:12] – Prednisone, COVID & Anxiety: Personal Case Story Guest Dr. Curt Dearing shares: Followed COVID protocol including prednisone Developed severe, prolonged anxiety afterward (twice) Realization that prednisone triggered it Ed's summary of prednisone side effects: bone loss, cataracts, muscle wasting, weight gain; okay short term, risky long term [0:33:30] – Cardiovascular Disease, Statins, & New Drug Lifendra (PCSK9 Inhibitor Pill) CV disease framed as leading cause of death for most people Introduction of Lifendra (oral PCSK9 inhibitor, from Merck) as “breakthrough” LDL-lowering drug Comparison with Repatha (injectable PCSK9 inhibitor) Curt's key points: Lifendra lowers LDL but does not show reduction in cardiovascular death, heart attack, or stroke (per Merck's own wording so far) Repatha's trial data: minimal impact on non-fatal events; no reduction in CV deaths vs. placebo Very high cost (~$300+/month out of pocket; heavy insurance burden) Critique of LDL obsession in cardiology Need to ask: Why is the cardiovascular system inflamed and oxidized? Ed & Curt's “terrain” model: Bad inputs: ultra-processed food, toxins, poor sleep, chronic stress, lack of sun/movement Missing inputs: nutrient-dense foods, minerals, omega-3s, organ meats, sunlight, sleep, movement Example of amlodipine: lowers BP numbers but may increase arterial calcification (calcium channel blocker) For people unwilling to change lifestyle, drugs may offer marginal benefit—but not true health [0:41:05] – Curt's Book & Lab Markers That Matter More Than LDL-C Curt's book: “Beyond Cholesterol: The Ultimate Guide to Testing and Supplements for Heart Health” Emphasis on better markers: ApoB, LDL particle size/number, calcium score, etc. Book's Amazon performance briefly noted (new release bestseller in its category) [0:44:32] – Alternatives to Statins & PCSK9s: Bergamot & Lifestyle Curt's hierarchy: Lifestyle (diet, exercise, stress, sleep) Targeted supplements like bergamot (citrus extract): lowers harmful particles such as ApoB and supports “good” LDL function Only then consider pharmaceuticals, and very selectively Skepticism about recommending Lifendra at all; strong bias toward non-drug approaches [0:45:28] – Dr. Wolfson, Mold, and Cardiovascular Terrain Ed & Curt's respect for Dr. Jack Wolfson, “The Natural Heart Doctor” Mention of mold as a major, under-recognized driver of cardiovascular disease Reference to Dr. Wolfson's educational resources and upcoming podcast plans [0:48:04] – Key Takeaways on Lifendra & Heart Prevention Strategy Lifendra will not fix: seed oils, glyphosate exposure, mold, bad sleep, chronic stress Terrain-building priorities: Real food, omega-3s, sunlight Toxin reduction Mitochondrial support Foundational supplements Contrast: drugs = band-aids with side effects; nutraceuticals = “side benefits” when used correctly [0:52:28] – Wrap-Up Ed mentions Sprouts selling lab-grown meat and his strong opposition Update on Oura Ring: now tracking nighttime blood pressure and importance of BP dipping Listener story: young man post–heart surgery credits Nutrition World's education and support with changing his life Final thanks to Dr. Dearing and closing outro  The post Radio Show / Podcast – August 9, 2026 first appeared on Vital Health Radio.

Heart disease remains the leading cause of death worldwide, yet many cardiovascular events occur in people whose cholesterol levels and routine cardiac tests appear completely normal. In this episode, I sit down with Dr. Sanjay Bhojraj, an interventional cardiologist and  founder of the Integrative Heart Institute, to explore why preventing heart disease requires looking far beyond traditional risk factors. Together, we discuss the Integrative HEART Framework, a comprehensive approach to cardiovascular prevention that considers inflammation, metabolic health, mitochondrial function, hormones, nervous system regulation, sleep, environmental toxins, and advanced diagnostics. Dr. Bhojraj also explains how wearable technology, precision imaging, genomics, and lifestyle medicine are transforming the future of heart care by identifying risk years before symptoms develop. If you're looking to better understand your cardiovascular health, prevent disease before it starts, and discover how integrative medicine is reshaping heart care, this conversation is a must-listen. Key takeaways: Cardiovascular health requires a comprehensive approach that goes beyond monitoring cholesterol and blood pressure; lifestyle, metabolic health, and stress play crucial roles. Integrative Heart Framework (HEART): Hormone optimization, Energy regulation, Autonomic nervous system healing, Rest and recovery, and Toxin reduction. Hormones and metabolism significantly affect heart health, and therapies like testosterone replacement can be beneficial. New diagnostic methods such as coronary CT angiograms are pivotal for assessing soft plaque and preventing heart attacks. Simple lifestyle changes often outperform complex medical interventions in maintaining long-term heart health.   More About Dr. Sanjay Bhojraj: Dr. Sanjay Bhojraj, MD, IFMCP is an interventional cardiologist and leader in precision, functional, and integrative cardiovascular medicine. After nearly two decades performing life-saving cardiac procedures—including coronary stents, structural heart interventions, and emergency heart attack care—he began asking a different question: Why are so many people developing heart disease in the first place? Today, Dr. Bhojraj is the founder of the Integrative Heart Institute, where he combines the best of conventional cardiology with functional medicine, genomics, advanced imaging, lifestyle medicine, and emerging longevity science to identify and address the root causes of cardiovascular disease before catastrophic events occur. He is a Certified Practitioner with the Institute for Functional Medicine (IFM), serves as faculty for both IFM and the Academy for Anti-Aging Medicine (A4M), and completed his cardiology and interventional cardiology training at Henry Ford Hospital after graduating from Indiana University School of Medicine. Dr. Bhojraj developed the Integrative HEART Framework—a comprehensive model that expands cardiovascular risk assessment beyond cholesterol and blood pressure to include hormones, mitochondrial health, autonomic function, recovery and sleep, environmental toxins, inflammation, metabolism, and precision diagnostics. His mission is to help patients build resilient cardiovascular health rather than simply manage disease after it appears. He is also host of The Curious Cardiologist podcast, where he interviews leading experts at the intersection of cardiology, functional medicine, longevity, and human performance. Website Instagram Connect with me! Website Instagram Facebook YouTube

Precision Hormone Health: Testosterone, Menopause, Muscle, Sleep, and Proactive Longevity: Endocrinologist Dr. Florence Comite details her book “Invincible: Defy Your Genetic Destiny to Live Better, Longer” and her precision-medicine approach to proactive longevity. She discusses testosterone decline beginning in the 30s in both sexes, stress-related low T (including in special forces), and testosterone's roles in energy, cognition, motivation, muscle, bone, and chronic disease risk. Comite argues genes are a “draft” and health destiny can be altered through epigenetic-like choices, individualized data, and early monitoring. For women, she emphasizes estrogen, progesterone, and testosterone in perimenopause/menopause, preferring bioidentical hormones and criticizing WHI's use of Premarin/Provera and older participants. She covers osteoporosis prevention, muscle as an “organ of longevity,” protein intake, resistance training, continuous glucose monitors for individualized diet, sleep quality tracking via wearables, and selective use of DHEA, pregnenolone, growth hormone pathways, and peptides with attention to sourcing and risk.

Send us Fan MailFor years, women have been told that weight gain, irregular cycles, insulin resistance, elevated cholesterol, fatigue, and hormone imbalances are separate problems requiring separate solutions.But what if they're all connected?In this episode, Cody sits down with Dr. Sirisha Vadali, board-certified cardiologist, advanced lipidologist, and Program Director of HonorHealth's Cardiometabolic Program, to explore the growing understanding of women's metabolic health and why experts are rethinking the way we approach conditions like PCOS.Dr. Vadali explains why many experts now support the term PMOS (Polyendocrine Metabolic Ovarian Syndrome), recognizing that this condition affects far more than the ovaries. Together, they discuss how hormones, insulin resistance, inflammation, metabolism, and cardiovascular health are deeply interconnected—and why understanding that bigger picture can completely change a woman's approach to her health.Whether you've struggled with weight loss, elevated cholesterol, insulin resistance, irregular cycles, or simply feel like your symptoms haven't been taken seriously, this conversation offers both validation and practical hope.In This Episode You'll Learn: Why many experts are advocating for the shift from PCOS to PMOS  The surprising relationship between hormones, insulin resistance, and metabolism  Why cardiovascular health should be part of every woman's hormone conversation  Early signs of insulin resistance that often go unnoticed  Why women are frequently dismissed or misdiagnosed  How inflammation impacts hormones and long-term health  What cholesterol really tells us about metabolic health  Lifestyle habits that have the greatest impact on insulin sensitivity  Why quick fixes rarely create lasting results  Practical ways to reduce future cardiometabolic risk Key TakeawayWomen's health isn't just about hormones.It's about understanding how hormones, metabolism, inflammation, insulin, and cardiovascular health all work together.When we stop treating symptoms in isolation and begin supporting the whole system, we create a much stronger foundation for long-term health.About Our GuestDr. Sirisha Vadali is a board-certified cardiologist, advanced lipidologist, and Program Director of Honor Health's Cardiometabolic Program. Having cared for more than 120,000 patients, she is passionate about prevention and helping women better understand the connection between metabolic health, hormones, cardiovascular disease, and longevity.Connect with Dr. Sirisha VadaliIf you'd like to learn more from Dr. Vadali or connect with her work, you can find her here:

Dr. Gary McGowan drops in to share a masterclass on cardiovascular disease and its major risk factors, including:The relationship between cholesterol and cardiovascular diseaseWhy LDL cholesterol is importantWhat causes LDL cholesterol to riseThe dietary factors that can increase LDL cholesterolNavigating misleading claims about LDL from the carnivore diet communityWhy elimination diets can appear to improve someone's healthThe relationship between obesity and cardiovascular diseaseWhy not all fat storage in the body is associated with the same level of disease riskVisceral fat, BMI, and the personal fat thresholdWhy cardiovascular risk accumulates over timeThe role of genetics in cholesterol and blood pressureWhat causes high blood pressureThe role of dietary sodium in hypertensionThe most important lifestyle behaviours for lowering cardiovascular disease riskHow to screen for atherosclerotic plaque buildup in your arteriesCoronary artery calcium scans and CCTA imagingWhether caffeine and energy drinks increase the risk of heart problemsAnd much moreFollow Gary on Instagram:@drgarymcgowanCHAPTERS01:31 Cholesterol and Heart Risk04:50 Why LDL Rises06:23 Diet Drivers of LDL09:31 Coffee and Cholesterol10:32 Exercise and Lipids12:19 Carnivore LDL Debate18:32 Elimination Diet Reality21:48 Obesity and Heart Disease26:26 Visceral Fat and BMI31:15 BMI Reality Check32:24 Personal Fat Threshold32:46 Obesity Over Time33:58 Cumulative Risk Model34:58 Blood Pressure Drivers36:04 Salt and the Modern Diet38:21 Lifestyle Risk Pillars38:53 Heart Plaque Screening41:32 Calcium Scans Explained44:33 CCTA for Soft Plaque48:17 Caffeine and Heart Risk53:14 Energy Drink Extremes55:21 Where to Find Gary57:34 Final Wrap-UpSUPPORT THE SHOWIf this episode helped you better understand cholesterol, blood pressure, or cardiovascular disease risk, you can support the show by:Subscribing and checking out more episodesSharing it on social media — tag me and I'll respondSending it to someone who is confused about cholesterol, blood pressure, or heart healthFOLLOW ANDREW COATESInstagram: @andrewcoatesfitnesshttps://www.andrewcoatesfitness.comPARTNERS AND RESOURCESRP STRENGTH APPUse code COATESRP:https://www.rpstrength.com/coatesJUST BITE ME MEALSUse code ANDREWCOATESFITNESS for 10% off:https://justbitememeals.comMACROSFIRST – FREE PREMIUM TRIALDownload MacrosFirst and during setup you'll be asked:“How did you hear about us?”Type in the code: ANDREWKNKG BAGS – 15% OFFhttps://www.knkg.com/Andrew59676VERSA GRIPPShttps://www.versagripps.com/andrewcoatesTRAINHEROIC – FREE 90-DAY TRIALComplete these two steps:Go to:https://www.trainheroic.com/liftfreeReply to the email you receive — or email trials@trainheroic.com — and let them know Andrew sent you.L1 BIOMECHANICS AND ASSESSMENT COURSEUse code COATES:https://pro.activelifeprofessional.com/assessmentworkshopevents

Skin cancer comes from the sun. But so do many good things, according to author Rowan Jacobsen. Jacobsen talks with EconTalk's Russ Roberts about the health benefits of sunshine and makes the case for prudent sun exposure. Topics discussed include the "heliotherapy" movement that peaked in the early 1900s in response to rickets and tuberculosis, why diagnosing skin cancer is on the rise, and why yesterday's sunscreens may have done more harm than good.